YEAR IN REVIEW 2018
This post reflects on a busy and successful year for RCP, as it reached its ten year anniversary.
Over the last decade RCP has invested millions of pounds into early stage companies.
RCP made a number of new and follow-on investments in 2018, including:
Oxford Biotherapeutics - committed to the discovery and development of novel therapies for various cancer types.
Appy Parking - a software that shows on-street and off-street parking options in major cities in the UK.
Micrima - developing technology for breast cancer screening that is painless and side-effect free.
AMTE - bringing new energy storage solutions to UK manufacturing.
Centauri - focused on the discovery and development of novel molecules targeting life threatening diseases.
RCP also made two exits at a premium in 2018, FCFM and Two Chicks.
Going forward, RCP will continue to focus on innovative businesses that are looking for funding to support their growth.
We expect to announce some exciting new investments in early 2019.
RCP started work on two new projects in 2018, the Penthouse and Commercial unit at Randall Court.
RCP are actively searching for the next development project in London and the surrounding counties, with a focus on creating premium quality homes.
Renaissance Capital Partners Ltd. is a private company established in 2008 to invest funds in high-growth, innovative and entrepreneurial businesses. It now has a diverse investment portfolio across various industries including Health, Fund Management, Clean Tech, Media and Real Estate Development.